Consistency with approval or certification particulars
Align the brand name, generic device name, intended use, specifications, components, and other relevant information with the submission.
Statutory labeling and package inserts for Japan cannot be prepared simply by translating overseas labels or operating instructions.
They need to reflect Japanese approval or certification particulars, statutory labeling requirements, safety information, and how the device is actually used.
On this page, “package inserts” includes electronic package inserts.
To learn how to find Japanese package inserts in PMDA's database, see How to Search Medical Device Package Inserts in Japan.
Statutory labeling and package inserts communicate approval or certification particulars and information needed for safe use to healthcare professionals.
Intended use, warnings, contraindications, precautions, and operating instructions must not conflict with the submission documents or risk management documentation.
Align the brand name, generic device name, intended use, specifications, components, and other relevant information with the submission.
Include the required information, such as the Marketing Authorization Holder (MAH), approval, certification or notification number, lot or serial number, expiration date, and storage conditions.
Base the content on risk management, test results, clinical evaluation, known malfunctions, and other relevant evidence.
Clearly describe preparation, operation, compatible devices, and precautions so that healthcare professionals can use the device safely.
Prepare the information needed for safe use, including warnings, contraindications and prohibitions, precautions, malfunctions, and adverse events.
Assess how changes to labeling or package inserts affect approved or certified particulars, QMS documentation, risk management, and products already on the market.
Display the required information on containers, packaging, the device itself, or other applicable locations. This includes information such as the MAH, approval, certification or notification number, lot number, and expiration date.
Provide information needed for the appropriate and safe use of the medical device.
Explain how to use the product, including preparation, connections, operation, troubleshooting, maintenance, and disposal.
Ensure that intended use, warnings, precautions, terminology, and product specifications do not conflict across these documents.
Review the latest labels, operating instructions, risk management documentation, test reports, clinical evaluation, and other relevant materials.
Check intended use, specifications, components, warnings, performance, and other particulars against the Japanese submission.
Address statutory labeling, MAH information, Japanese wording, and precautions for the Japanese market.
Review terminology, illustrations, operating steps, units, and references to make sure the information can be understood without ambiguity.
Incorporate the particulars finalized during review or certification into labeling and package inserts.
Define how to handle safety information, revision history, products already on the market, and communication with distributors.
For ERCP devices, guidewires, cannulas, stone retrieval baskets, balloons, and biliary or pancreatic stents, the clinical workflow and compatibility with other devices are important.
No. They need to be prepared in accordance with the Japanese approval or certification particulars, statutory labeling requirements, warnings, contraindications, and precautions.
They serve different purposes. Package inserts present information for appropriate and safe use, while IFU explain specific operating methods and other practical instructions.
Yes, but depending on the change, its impact on approved or certified particulars, QMS, risk management, and other relevant areas needs to be assessed.
IVDs have product-specific regulatory and labeling considerations. Their Japanese labeling and package-insert review should reflect the IVD product category, intended diagnostic use and authorized product information.
For official information on electronic package inserts in Japan, refer to the following PMDA source.
We review overseas documents and the Japanese submission to identify what needs to be aligned across statutory labeling, package inserts, and IFU.
Discuss Your Labeling Requirements